Evotec SE/ DE0005664809 /
30/10/2024 15:14:02 | Diferencia - | Volumen | Bid29/10/2024 | Ask15:14:02 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.29EUR | - | 255 Volumen de negocios: 1,857.68 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 1.35 mil millonesEUR | - | - |
GlobeNewswire
16/01
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and ...
GlobeNewswire
11/12/2023
Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire
07/11/2023
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire
11/10/2021
Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement
GlobeNewswire
26/04/2021
Proactive news headlines including Chase Mining Corporation, Red River Resources, Aurumin and Kazia ...
GlobeNewswire
20/04/2021
Proactive news headlines including Queensland Pacific Metals, Moho Resources, Kazia Therapeutics and...
GlobeNewswire
01/03/2021
Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Preci...
GlobeNewswire
04/06/2020
Toronto Innovation Acceleration Partners Expands its LAB150 Portfolio with a Novel Cancer Therapeut...
GlobeNewswire
12/12/2019
Toronto Innovation Acceleration Partners (TIAP) adds novel KRAS oncology project to its LAB150 portf...
GlobeNewswire
11/06/2019
Mental Health is Focus of New High-Potential Anti-Depression Project from MaRS Innovation and the Ce...
GlobeNewswire
15/02/2018
EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire
08/01/2018
APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire
14/09/2017
MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
GlobeNewswire
29/11/2011
Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire
27/10/2011
Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página